Utah Was Really Into Trump’s Miracle Cure. Now It Wants Its Money Back.

Kevin E. Schmidt/Quad-City Times via ZUMA Wire

The coronavirus is a rapidly developing news story, so some of the content in this article might be out of date. Check out our most recent coverage of the coronavirus crisis, and subscribe to the Mother Jones Daily newsletter.

Utah residents may be lukewarm on President Donald Trump—the president leads Democrat Joe Biden there by only five points, a shocking number in such a reliably red state—but Utah has proven to be an enthusiastic booster of Trump’s favorite coronavirus miracle cure, the anti-malaria drug hydroxychloroquine. On March 21, a group of drug promoters in the state held a press conference to advocate for its use to treat Covid-19, claiming it could practically raise the dead, despite the fact that there’s no evidence that it works, and plenty of evidence that it can be dangerous to some people.

“There are responses that are equivalent to Lazarus—literally the biblical Lazarus—people almost dead coming back,” physician Kurt Hegmann, director of the Rocky Mountain Center for Occupational and Environmental Health at the University of Utah, said at the event.

Ten days later, the state spent $800,000 to purchase 20,000 doses from a local pharmacy chain, Meds in Motion, whose owner had been promoting the drug to state officials for weeks. The state legislature planned to set aside $8 million to buy 200,000 more doses to distribute free of charge to anyone diagnosed with COVID-19. Experts warned that the purchase was a waste of money given that the drug hasn’t been proven to work in treating the disease.

Eight million dollars for pharmaceuticals is a lot of money in a state that ranks dead last in per-pupil public school spending and spent most of the last decade refusing to expand Medicaid under Obamacare, even after state residents passed a ballot initiative demanding the expansion.

Utah House Democrats were suspicious of the GOP state officials’ enthusiasm for the unproven drug. They released a press statement criticizing the purchase, noting that their GOP colleagues had been pushing to buy the drugs from Dan Richards, the owner of Meds in Motion, who had amassed huge quantities of the raw materials needed to compound the drug and now wanted the state to buy his stash. Citing a recent study showing that hydroxychloroquine may endanger coronavirus patients, the state democrats said on April 21, “[O]ur colleagues quietly pushed the state to buy the stockpile of Dan Richards of Meds In Motion, a pharmacist lobbyist, with precious taxpayer dollars to compound the unproven drug without public scrutiny.”

“There is absolutely no need for us to spend money on this drug now,” they added. “It is also not clear how the decision to use state money was made, or where the money is coming from.”

Nonetheless, Utah officials moved forward, urged on by state Senate President Stuart Adams, who had appeared at the March press conference with Richards and the other drug promoters. But on Friday, after the FDA warned against negative impacts of the drug, Governor Gary Herbert announced that the state would not purchase any more hydroxychloroquine. He claimed to have no idea how the first batch got procured by his administration, which issued the no-bid contract under emergency procurement rules enacted because of the pandemic.

The 20,000 pills haven’t yet been delivered to the state health department, so Herbert suggested that the state should get a refund. “That’d be nice if they just said, you know, we had a miscommunication here and we’re apologizing and here’s your money back,” he said at a news conference Friday.

 

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with the Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

AN IMPORTANT UPDATE

We’re falling behind our online fundraising goals and we can’t sustain coming up short on donations month after month. Perhaps you’ve heard? It is impossibly hard in the news business right now, with layoffs intensifying and fancy new startups and funding going kaput.

The crisis facing journalism and democracy isn’t going away anytime soon. And neither is Mother Jones, our readers, or our unique way of doing in-depth reporting that exists to bring about change.

Which is exactly why, despite the challenges we face, we just took a big gulp and joined forces with the Center for Investigative Reporting, a team of ace journalists who create the amazing podcast and public radio show Reveal.

If you can part with even just a few bucks, please help us pick up the pace of donations. We simply can’t afford to keep falling behind on our fundraising targets month after month.

Editor-in-Chief Clara Jeffery said it well to our team recently, and that team 100 percent includes readers like you who make it all possible: “This is a year to prove that we can pull off this merger, grow our audiences and impact, attract more funding and keep growing. More broadly, it’s a year when the very future of both journalism and democracy is on the line. We have to go for every important story, every reader/listener/viewer, and leave it all on the field. I’m very proud of all the hard work that’s gotten us to this moment, and confident that we can meet it.”

Let’s do this. If you can right now, please support Mother Jones and investigative journalism with an urgently needed donation today.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate